Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024

Floor Speech

Date: Dec. 18, 2024
Location: Washington, DC


Mr. Speaker, H.R. 8663, the Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 is an important piece of legislation that enables the DHS Science and Technology Directorate to improve the capabilities of law enforcement at every level in identifying and combating illicit substances.

This bipartisan bill demonstrates a strong commitment to equipping law enforcement with the tools needed to combat the proliferation of dangerous substances like fentanyl and xylazine.

The bill specifically directs DHS S&T to develop and evaluate advanced drug detection technologies like machines that can break down and analyze complex drug mixtures and AI systems to spot new drug threats.

These initiatives aim to enhance the precision and efficiency of drug detection, empowering law enforcement to respond effectively to evolving challenges.

Furthermore, H.R. 8663, prioritizes collaboration with agencies like the DEA and adherence to NIST's artificial intelligence risk management framework, reinforcing the integrity and reliability of the technologies developed.

This bill is an important step in ensuring that DHS prioritizes the development and deployment of cutting-edge technologies to combat the growing threat of dangerous substances like fentanyl and xylazine so DHS will be better equipped to address emerging drug trends, protect public safety, and support law enforcement efforts nationwide.

Mr. Speaker, I encourage my colleagues to join me in supporting H.R.

Republicans and Democrats alike recognize the challenges facing law enforcement in the detection of dangerous drugs like fentanyl and xylazine.

H.R. 8663 is a step in the right direction, and we should send it to the President's desk today.

BREAK IN TRANSCRIPT


Source
arrow_upward